Exact Mass: 519.148034
Exact Mass Matches: 519.148034
Found 180 metabolites which its exact mass value is equals to given mass value 519.148034
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pelargonidin 3-(6'-malonylglucoside)
Pelargonidin 3-(6-malonylglucoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Pelargonidin 3-(6-malonylglucoside) is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Pelargonidin 3-(6-malonylglucoside) can be found in cloudberry, lupine, red raspberry, and strawberry, which makes pelargonidin 3-(6-malonylglucoside) a potential biomarker for the consumption of these food products.
Ceforanide
Ceforanide is a second-generation parenteral cephalosporin antibiotic. It has a longer elimination half-life than any currently available cephalosporin. Its activity is very similar to that of cefamandole, a second-generation cephalosporin, except that ceforanide is less active against most gram-positive organisms. Many coliforms, including Escherichia coli, Klebsiella, Enterobacter, and Proteus, are susceptible to ceforanide, as are most strains of Salmonella, Shigella, Hemophilus, Citrobacter and Arizona species. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Tenofovir disoproxil
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Gravacridonetriol glucoside
Gravacridonetriol glucoside is found in herbs and spices. Gravacridonetriol glucoside is an alkaloid from Ruta graveolens (rue
Aminodextran
Dabrafenib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EC - B-raf serine-threonine kinase (braf) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively[4].
Estramustine phosphate
Tenofovir disoproxil
Pelargonidin 3-(6-malonylglucoside)
Dabrafenib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EC - B-raf serine-threonine kinase (braf) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively[4].
C26H30ClNO8_2-{7-Acetoxy-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-7,8-dihydro-2(6H)-isoquinolinyl}pentanedioic acid
C26H30ClNO8 (519.1659850000001)
Ala Asp Glu Trp
C23H29N5O9 (519.1965184000001)
Ala Asp Trp Glu
C23H29N5O9 (519.1965184000001)
Ala Glu Asp Trp
C23H29N5O9 (519.1965184000001)
Ala Glu Trp Asp
C23H29N5O9 (519.1965184000001)
Ala Trp Asp Glu
C23H29N5O9 (519.1965184000001)
Ala Trp Glu Asp
C23H29N5O9 (519.1965184000001)
Cys Asp Pro Trp
Cys Asp Trp Pro
Cys Phe His Asn
Cys Phe Asn His
Cys His Phe Asn
Cys His Asn Phe
Cys Asn Phe His
Cys Asn His Phe
Cys Pro Asp Trp
Cys Pro Trp Asp
Cys Trp Asp Pro
Cys Trp Pro Asp
Asp Ala Glu Trp
C23H29N5O9 (519.1965184000001)
Asp Ala Trp Glu
C23H29N5O9 (519.1965184000001)
Asp Cys Pro Trp
Asp Cys Trp Pro
Asp Asp Asp Arg
Asp Asp Arg Asp
Asp Glu Ala Trp
C23H29N5O9 (519.1965184000001)
Asp Glu Glu Gln
Asp Glu Gln Glu
Asp Glu Trp Ala
C23H29N5O9 (519.1965184000001)
Asp Pro Cys Trp
Asp Pro Trp Cys
Asp Gln Glu Glu
Asp Arg Asp Asp
Asp Trp Ala Glu
C23H29N5O9 (519.1965184000001)
Asp Trp Cys Pro
Asp Trp Glu Ala
C23H29N5O9 (519.1965184000001)
Asp Trp Pro Cys
Glu Ala Asp Trp
C23H29N5O9 (519.1965184000001)
Glu Ala Trp Asp
C23H29N5O9 (519.1965184000001)
Glu Asp Ala Trp
C23H29N5O9 (519.1965184000001)
Glu Asp Glu Gln
Glu Asp Gln Glu
Glu Asp Trp Ala
C23H29N5O9 (519.1965184000001)
Glu Glu Asp Gln
Glu Glu Glu Asn
Glu Glu Gly Trp
C23H29N5O9 (519.1965184000001)
Glu Glu Asn Glu
Glu Glu Gln Asp
Glu Glu Trp Gly
C23H29N5O9 (519.1965184000001)
Glu Gly Glu Trp
C23H29N5O9 (519.1965184000001)
Glu Gly Trp Glu
C23H29N5O9 (519.1965184000001)
Glu Asn Glu Glu
Glu Gln Asp Glu
Glu Gln Glu Asp
Glu Trp Ala Asp
C23H29N5O9 (519.1965184000001)
Glu Trp Asp Ala
C23H29N5O9 (519.1965184000001)
Glu Trp Glu Gly
C23H29N5O9 (519.1965184000001)
Glu Trp Gly Glu
C23H29N5O9 (519.1965184000001)
Phe Cys His Asn
Phe Cys Asn His
Phe His Cys Asn
Phe His Asn Cys
Phe Asn Cys His
Phe Asn His Cys
Gly Glu Glu Trp
C23H29N5O9 (519.1965184000001)
Gly Glu Trp Glu
C23H29N5O9 (519.1965184000001)
Gly Trp Glu Glu
C23H29N5O9 (519.1965184000001)
His Cys Phe Asn
His Cys Asn Phe
His Phe Cys Asn
His Phe Asn Cys
His Asn Cys Phe
His Asn Phe Cys
Asn Cys Phe His
Asn Cys His Phe
Asn Glu Glu Glu
Asn Phe Cys His
Asn Phe His Cys
Asn His Cys Phe
Asn His Phe Cys
Pro Cys Asp Trp
Pro Cys Trp Asp
Pro Asp Cys Trp
Pro Asp Trp Cys
Pro Trp Cys Asp
Pro Trp Asp Cys
Gln Asp Glu Glu
Gln Glu Asp Glu
Gln Glu Glu Asp
Arg Asp Asp Asp
Trp Ala Asp Glu
C23H29N5O9 (519.1965184000001)
Trp Ala Glu Asp
C23H29N5O9 (519.1965184000001)
Trp Cys Asp Pro
Trp Cys Pro Asp
Trp Asp Ala Glu
C23H29N5O9 (519.1965184000001)
Trp Asp Cys Pro
Trp Asp Glu Ala
C23H29N5O9 (519.1965184000001)
Trp Asp Pro Cys
Trp Glu Ala Asp
C23H29N5O9 (519.1965184000001)
Trp Glu Asp Ala
C23H29N5O9 (519.1965184000001)
Trp Glu Glu Gly
C23H29N5O9 (519.1965184000001)
Trp Glu Gly Glu
C23H29N5O9 (519.1965184000001)
Trp Gly Glu Glu
C23H29N5O9 (519.1965184000001)
Trp Pro Cys Asp
Trp Pro Asp Cys
Gravacridonetriol glucoside
2-(BETA-D-GALACTOSIDOXY)NAPHTHOL AS-LC
C25H26ClNO9 (519.1296016000001)
Amrubicin hydrochloride
C25H26ClNO9 (519.1296016000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
1H-Azepine,1-[[4-[[4-(2-benzothiazolyl)-1-piperidinyl]sulfonyl]phenyl]sulfonyl]hexahydro-(9CI)
estramustine phosphate
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D000477 - Alkylating Agents
(S)-1-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy) -2-phenylbut-3- en-2-amine,Maleic acid
12-beta-D-Glucopyranosyl-12,13-dihydro-1,11-dihydroxy-5H-indolo(2,3-a)pyrrolo(3,4-C)carbazole-5,7(6H)-dione
C26H21N3O9 (519.1277736000001)
4-methyl-N-[2-[[2-[(4-methylphenyl)sulfonylamino]phenyl]iminomethyl]phenyl]benzenesulfonamide
2,3,4,5-Tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanamide
2-Thioxo-4-oxo-5-[3-[(alpha-methylbenzyl)oxy]-4-(phenethyloxy)benzylidene]thiazolidine-3-acetic acid
C28H25NO5S2 (519.1174080000001)
(2S)-naringenin 7-O-(6-O-malonyl-beta-D-glucoside)
2-[(2S,4aS,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(2S,4aR,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(2S,4aR,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(2R,4aR,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(2S,4aS,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide
[(1R)-2-(benzenesulfonyl)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O6S2 (519.1497694000001)
2-[(2R,4aS,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(2R,4aR,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(2R,4aS,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide
[(1R)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(2-pyrazinyl)methanone
[(1S)-2-(benzenesulfonyl)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O6S2 (519.1497694000001)
(6R,7S)-7-[[2-[2-(aminomethyl)phenyl]-1-oxoethyl]amino]-3-[[[1-(carboxymethyl)-5-tetrazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-[2-[(E,3E)-3-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)-2-methoxyprop-1-enyl]-1,3-benzothiazol-3-ium-3-yl]propane-1-sulfonic acid
Ceforanide
A second-generation cephalosporin antibiotic with {[1-(carboxymethyl)-1H-tetrazol-5-yl]sulfanyl}methyl and 2-(aminomethyl)phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is effective against many coliforms, including Escherichia coli, Klebsiella, Enterobacter and Proteus, and most strains of Salmonella, Shigella, Hemophilus, Citrobacter and Arizona species. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
1-{4-[(1e,3e)-4-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}buta-1,3-dien-1-yl]phenyl}-2-{4-[(1e,3e)-4-carboxybuta-1,3-dien-1-yl]phenyl}-1-hydroxydiazenium
(2r)-3-[(4a,8,12a,12b-tetrahydroxy-3-methyl-1,7,12-trioxo-5,6-dihydro-4h-tetraphen-6a-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid
aglaroxin a
{"Ingredient_id": "HBIN014862","Ingredient_name": "aglaroxin a","Alias": "NA","Ingredient_formula": "C29H29NO8","Ingredient_Smile": "CN(C)C(=O)C1C(C2(C(C1O)(C3=C(C4=C(C=C3O2)OCO4)OC)O)C5=CC=C(C=C5)OC)C6=CC=CC=C6","Ingredient_weight": "519.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "741","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15450360","DrugBank_id": "NA"}
Aristoloside
{"Ingredient_id": "HBIN016829","Ingredient_name": "Aristoloside","Alias": "aristoloside","Ingredient_formula": "C23H21NO13","Ingredient_Smile": "COC1=CC(=CC2=C3C(=C(C=C12)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O)OC5C(C(C(C(O5)CO)O)O)O","Ingredient_weight": "519.41","OB_score": "3.865093461","CAS_id": "84014-70-0","SymMap_id": "SMIT11792","TCMID_id": "1725","TCMSP_id": "MOL010802","TCM_ID_id": "6651","PubChem_id": "128576","DrugBank_id": "NA"}